EOG
56
-2
CAH
53
6
NTRS
57
2
SRE
66
3
ROST
52
5
APA
24
3
KMX
64
6
XYL
45
8
JPM
67
4
TROW
51
3
WDC
43
2
HOG
33
4
URBN
42
4
PSA
56
5
SLG
66
2
BAX
30
4
PLD
48
-5
CMI
64
5
EXPE
91
3
AMAT
42
6
EOG
56
-2
CAH
53
6
NTRS
57
2
SRE
66
3
ROST
52
5
APA
24
3
KMX
64
6
XYL
45
8
JPM
67
4
TROW
51
3
WDC
43
2
HOG
33
4
URBN
42
4
PSA
56
5
SLG
66
2
BAX
30
4
PLD
48
-5
CMI
64
5
EXPE
91
3
AMAT
42
6
Financhill
Back

XTL Biopharmaceuticals Vs. Can Fite Biofarma Industry Stock Comparison

Sell
23

XTLB
XTL Biopharmaceuticals

Last Price:
1.83
Seasonality Move:
1.39%
Sell
42

CANF
Can Fite Biofarma

Last Price:
2.00
Seasonality Move:
-4.74%
Sell
23
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

  • The current XTL Biopharmaceuticals [XTLB] share price is $1.83. The Score for XTLB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • XTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.97. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

  • The XTL Biopharmaceuticals share price today is $1.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

XTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 46.65 Sell
Chaikin Money Flow: 6083 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 2.03) Buy
Bollinger Bands (100): (1.99 - 2.75) Sell

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 36.2 Sell
Chaikin Money Flow: -53828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.97 - 2.55) Sell
Bollinger Bands (100): (1.98 - 3.06) Sell

XTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Buy
20-day SMA: 1.85 Sell
50-day SMA: 2.1 Sell
200-day SMA: 2.23 Sell
8-day EMA: 1.81 Buy
20-day EMA: 1.86 Sell
50-day EMA: 2.05 Sell
200-day EMA: 2.1 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.01 Sell
20-day SMA: 2.14 Sell
50-day SMA: 2.22 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.02 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.25 Sell
200-day EMA: 2.46 Sell

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

XTL Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):